MT
Monocacy Therapeutics Inc.
StreetZero Signal 62
About Monocacy Therapeutics Inc.
Monocacy Therapeutics Inc. is a biotechnology company located in Monrovia, MD. It completed a $25,000 private placement. Founder and CEO Shashank Patel, based in Clarksburg, Maryland, has referenced recognition from TEDCO and MBIA for the company's innovation.
LATEST FUNDINGPrivate Placement
$25K
Announced 2026-10-07
TOTAL RAISED$25,000
IN THE NEWS
- ๐ Biotechnology Funding Tracker (1,094 deals) โ New Market Pitch
- ๐ Follow The Money: How Biotechโs Funding Shapes Its Direction
- ๐ Metware Biotechnology Inc - 2026 Company Profile, Funding & Competitors - Tracxn
- ๐ PAEAN Biotechnology - 2026 Company Profile, Funding & Competitors - Tracxn
- ๐ Shashank Patel - Founder, Board Member, Ex-NHGRI, NCI ...
EMPLOYEESโ
FOUNDEDโ
HQMonrovia, MD, United States
Industry
Biotechnology
Tags
Biotechnology
Investors
Not disclosed in the source filing. Form D filings do not list investors โ StreetZero surfaces them from news where available.
Key highlights
- Completed a $25,000 private placement in biotechnology sector.
- Located in Monrovia, MD with founder Shashank Patel in nearby Clarksburg, MD.
- Received recognition from TEDCO and MBIA for innovation.
Ask StreetZero about Monocacy Therapeutics Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account